Tratamiento de la obesidad

Arrizabalaga, 2003, Guía de práctica clínica para el manejo del sobrepeso y la obesidad en personas adultas, Endocrinología, 50, 1 Obesidad y sobrepeso. Nota descriptiva n° 311. Junio 2016. Organización Mundial de la Salud. Disponible en: http://www.who.int/mediacentre/factsheets/fs311/es/ [Consultado 7 de noviembre de 2016]. Popkin, 2015, Nutrition transition and the global diabetes epidemic, Curr Diab Rep., 15, 64, 10.1007/s11892-015-0631-4 Gutiérrez-Fisac, 2012, Prevalence of general and abdominal obesity in the adult population of Spain, 2008-2010: the ENRICA study, Obes Rev., 13, 388, 10.1111/j.1467-789X.2011.00964.x 2011, Estudio de prevalencia de la obesidad infantil: Estudio ALADINO (Alimentación, Actividad física, Desarrollo Infantil y Obesidad), Pediatría Aten Primaria, 13, 493, 10.4321/S1139-76322011000300015 Cole, 2000, Establishing a standard definition for child overweight and obesity worldwide: international survey, Br Med J., 320, 1240, 10.1136/bmj.320.7244.1240 1998, AACE/ACE position statement on the prevention, diagnosis and treatment of obesity, Endocrine Practice, 4, 297 1998, Obes Res., 6, 51S Romero-Corral, 2010, Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality, Eur Heart J., 31, 737, 10.1093/eurheartj/ehp487 Sahakyan, 2015, Normal-weight central obesity: implications for total and cardiovascular mortality, Ann Intern Med., 163, 827, 10.7326/M14-2525 Salvador, 2004, Obesidad. Concepto. Clasificación. Implicaciones fisiopatológicas. Complicaciones asociadas. Valoración clínica, Medicine, 9, 1167 Garvey, 2013, New tools for weight loss therapy enable a more robust medical model for obesity treatment: rationale for a complications-centric model, Endocrine Practice, 19, 864, 10.4158/EP13263.RA Guo F, Garvey WT. A new cardiometabolic risk staging system to guide treatment for obesity using a complications-centric approach: validation using CARDIA and NHANES data. American Association of Clinical Endocrinologists 22nd Annual Scientific and Clinical Congress. Sharma, 2009, A proposed clinical staging system for obesity, Inter J Obesity, 33, 289295, 10.1038/ijo.2009.2 Padwal, 2011, Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity, CMAJ, 183, 1059, 10.1503/cmaj.110387 De Cos, 2015, Riesgo asociado a obesidad según estadiaje de Edmonton en cirugía bariátrica, Nutr Hosp., 31, 196 2011, Recomendaciones nutricionales basadas en la evidencia para la prevención y el tratamiento del sobrepeso y la obesidad en adultos (Consenso FESNAD-SEEDO), Revista Española de Obesidad, 10, 1 Predimed Plus. Información disponible en: http://predimedplus.com/ Pérez de la Cruz AJ, Luna López V, Culebras Fernández JM. Nutrición y Obesidad. Nutrición clínica. Tomo IV. A Gil, editor. En: Planas M, Álvarez J, Culebras JM, García de Lorenzo A, León M, Maldonado J, et al, coordinadores. Tratado de nutrición clínica. Madrid: Editorial Médica Panamericana; 2010. p. 419-43. 2015, Panel on dietetic products, nutrition and allergies. Scientific Opinion on the essential composition of total diet replacements for weight control, EFSA Journal, 13, 3957, 10.2903/j.efsa.2015.3957 Dietas milagro. Disponible en: http://www.aesan.msssi.gob.es/AECOSAN/web/para_el_consumidor/ampliacion/dietas.shtml Boulange, 2016, Impact of the gut microbiota on inflammation, obesity, and metabolic disease, Genome Medicine, 8, 42, 10.1186/s13073-016-0303-2 Lam, 2016, Strategies for successful recruitment of young adults to healthy lifestyle programmes for the prevention of weight gain: a systematic review, Obes Rev., 17, 178, 10.1111/obr.12350 Johns, 2014, Diet or exercise interventions vs combined behavioral weight management programs: a systematic review and meta-analysis of direct comparisons, J Acad Nutr Diet., 114, 1557, 10.1016/j.jand.2014.07.005 Apovian, 2015, Pharmacological management of obesity: an endocrine Society clinical practice guideline, J Clin Endocrinol Metab., 100, 342, 10.1210/jc.2014-3415 Phung, 2010, Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes, JAMA, 303, 1410, 10.1001/jama.2010.405 Rosenfeld, 1997, Topiramate: a review of preclinical, pharmacokinetic, and clinical data, Clin Ther., 19, 1294, 10.1016/S0149-2918(97)80006-9 Astrup, 2012, Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide, Int J Obes (Lond), 36, 843, 10.1038/ijo.2011.158 McElroy, 2003, Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial, Am J Psychiatry., 160, 255, 10.1176/appi.ajp.160.2.255 Valsamakis, 2014, New molecular targets in the pathophysiology of obesity and available treatment options under investigation, Clin Obes., 4, 209 Mordes, 2015, Medications for weight loss, Curr Opin Endocrinol Diabetes Obes., 22, 91, 10.1097/MED.0000000000000140 Peene, 2014, Sodium glucose transporter protein 2 inhibitors: focusing on the kidney to treat type 2 diabetes, Ther Adv Endocrinol Metab., 5, 124, 10.1177/2042018814553965 Buchwald, 2009, Weight and type 2 diabetes after bariatric surgery:systematic review and meta-analysis, Am J Med., 122, 248, 10.1016/j.amjmed.2008.09.041 Sjöström, 2013, Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery, J Intern Med., 273, 219, 10.1111/joim.12012 1992, Gastrointestinal surgery for severe obesity: National Institute of Health Consensus Development Conference Statement, Am J Clin Nutr., 55 Rubio, 2004, Documento de consenso sobre cirugía bariátrica, Rev Esp Obes., 4, 223 Casanueva FF, de la Cruz Vigo F, Goday A, Ruiz de Adana JC, Monereo S, Vilallonga R, et al Declaración SECO-SEEDO sobre el tratamiento actual de la obesidad grave en España. 2015. Disponible en: http://www.seco.org/images/stories/seco/Cronicas_congreso/Tratamiento_actual_de_la_obesidad_grave_en_Espana_Declaracion_SECO_SEEDO2015.pdf [Consultado septiembre 2016]. Fried, 2013, Interdisciplinary European Guidelines on metabolic and bariatric surgery. European Association for the Study of Obesity; International Federation for the Surgery of Obesity - European Chapter, Obes Facts, 6, 449, 10.1159/000355480 O’Brien, 2013, Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature, Ann Surg., 257, 87, 10.1097/SLA.0b013e31827b6c02 Buchwald, 2003, A bariatric algorithm, Obes Surg., 12, 733, 10.1381/096089202320995484